PHAIM AIM ANTIGENIC IMMUNE MODULATION

Welcome to the Brand page for “PHAIM AIM ANTIGENIC IMMUNE MODULATION”, which is offered here for Vaccines; chemical preparations for the diagnosis of diabetes; pharmaceutical preparations for the prevention of diabetes; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for the prevention of disorders of the immune system; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the prevention of autoimmune disorders; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations; chemical preparations for medical purposes;advertising services relating to pharmaceuticals for the treatment of diabetes; advertising services relating to pharmaceuticals; advertising, marketing and promotional services; advertising; compilation of statistical data for use in scientific research; compilation of statistical data relating to medical research; advertising services to promote public awareness of medical conditions; advertising services related to immune disorders; advertising services related to autoimmune diseases;diabetes screening services; medical services in the field of diabetes; providing information via the internet in the field of diabetes; medical screening; health screening services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical services for the diagnosis of conditions of the human body; medical services; medical diagnostic services; medical services for the treatment of conditions of the human body; medical testing services relating to the diagnosis and treatment of disease; performing diagnosis of diseases; medical information services provided via the internet; providing medical information; medical analysis services for autoimmune disease diagnosis and prognosis;medical test kits for diabetes monitoring for home use; testing instruments for medical diagnostic purposes; blood glucose testing apparatus; apparatus for carrying-out diagnostic tests for medical purposes; diagnostic, examination, and monitoring equipment; medical apparatus for testing the level of glucose in the blood; medical apparatus and instruments; medical diagnostic instruments; medical testing instruments;antigenic immune modulation;.

Its status is currently believed to be active. Its class is unavailable. “PHAIM AIM ANTIGENIC IMMUNE MODULATION” is believed to be currently owned by “Phaim Pharma Ltd”.